Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2010

01.02.2010 | Preclinical study

Abnormal muscles that may affect axillary lymphadenectomy: surgical anatomy

verfasst von: K. Natsis, K. Vlasis, T. Totlis, G. Paraskevas, G. Noussios, P. Skandalakis, J. Koebke

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose The present study aimed at summarizing and presenting the anomalous muscles that a surgeon might encounter during axillary lymphadenectomy (AL). Methods For this purpose, both the anatomical and surgical literature was reviewed and an anatomical study on 107 cadavers was carried out. Furthermore, based on the anatomical features of the anomalous muscles that came up during our study and taking into consideration the landmarks of the AL, we further analyzed the complications that may arise from each of these muscles, along with their preoperative and intraoperative recognition and management. Results The literature review revealed that there are three supernumerary muscles that may affect the AL, namely the Langer’s axillary arch, the pectoralis quartus and the chondroepitrochlearis muscles, as well as the aplasia of the lower part of the pectoralis major muscle. Eight out of the 107 (7.48%) cadavers that we dissected had such an abnormal muscle in the axilla. Specifically, the axillary arch was found unilaterally in five cadavers (4.67%) and the pectoralis quartus muscle was present unilaterally in three cadavers (2.8%). One cadaver had both an axillary arch and a pectoralis quartus muscle in the right side. The abdominal and almost the whole sternocostal portion of the pectoralis major as well the pectoralis minor muscle were absent in one cadaver (0.93%). The chondroepitrochlearis muscle was not found in any of the cadavers that we dissected. Conclusions The present study offers the necessary preoperative knowledge for recognizing these muscles during AL, avoiding thus the complications that may arise from them.
Literatur
1.
Zurück zum Zitat Standring S (2005) Gray’s Anatomy, 39th edn. Elsevier, Edinburgh, p 962 Standring S (2005) Gray’s Anatomy, 39th edn. Elsevier, Edinburgh, p 962
2.
Zurück zum Zitat Bergman RA (1991) Doubled pectoralis quartus, axillary arch, chondroepitrochlearis, and the twist of the tendon of pectoralis major. Anat Anz 173:23–26PubMed Bergman RA (1991) Doubled pectoralis quartus, axillary arch, chondroepitrochlearis, and the twist of the tendon of pectoralis major. Anat Anz 173:23–26PubMed
3.
Zurück zum Zitat Bergman RA, Afifi AK, Miyouchi R (2007) Pectoralis major and pectoralis minor. In: Illustrated encyclopedia of human anatomic variation, part I: muscular system. http://www.vh.org. Accessed Nov 2008 Bergman RA, Afifi AK, Miyouchi R (2007) Pectoralis major and pectoralis minor. In: Illustrated encyclopedia of human anatomic variation, part I: muscular system. http://​www.​vh.​org. Accessed Nov 2008
4.
Zurück zum Zitat Bonastre V, Rodríguez-Niedenführ M, Choi D, Sañudo JR (2002) Coexistence of a pectoralis quartus muscle and an unusual axillary arch: case report and review. Clin Anat 15:366–370. doi:10.1002/ca.10053 CrossRefPubMed Bonastre V, Rodríguez-Niedenführ M, Choi D, Sañudo JR (2002) Coexistence of a pectoralis quartus muscle and an unusual axillary arch: case report and review. Clin Anat 15:366–370. doi:10.​1002/​ca.​10053 CrossRefPubMed
7.
Zurück zum Zitat Loukas M, South G, Louis RG Jr, Fogg QA, Davis T (2006) A case of an anomalous pectoralis major muscle. Folia Morphol (Warsz) 65:100–103 Loukas M, South G, Louis RG Jr, Fogg QA, Davis T (2006) A case of an anomalous pectoralis major muscle. Folia Morphol (Warsz) 65:100–103
8.
Zurück zum Zitat Mérida-Velasco JR, Rodríguez Vázquez JF, Mérida Velasco JA, Sobrado Pérez J, Jiménez Collado J (2003) Axillary arch: potential cause of neurovascular compression syndrome. Clin Anat 16:514–519. doi:10.1002/ca.10143 CrossRefPubMed Mérida-Velasco JR, Rodríguez Vázquez JF, Mérida Velasco JA, Sobrado Pérez J, Jiménez Collado J (2003) Axillary arch: potential cause of neurovascular compression syndrome. Clin Anat 16:514–519. doi:10.​1002/​ca.​10143 CrossRefPubMed
9.
Zurück zum Zitat Rizk E, Harbaugh K (2008) The muscular axillary arch: an anatomic study and clinical considerations. Neurosurgery 63:316–319PubMedCrossRef Rizk E, Harbaugh K (2008) The muscular axillary arch: an anatomic study and clinical considerations. Neurosurgery 63:316–319PubMedCrossRef
12.
Zurück zum Zitat Besana-Ciani I, Greenall MJ (2005) Langer’s axillary arch: anatomy, embryological features and surgical implications. Surgeon 3:325–327CrossRefPubMed Besana-Ciani I, Greenall MJ (2005) Langer’s axillary arch: anatomy, embryological features and surgical implications. Surgeon 3:325–327CrossRefPubMed
15.
Zurück zum Zitat Sachatello CR (1977) The axillopectoral muscle (Langer’s axillary arch): a cause of axillary vein obstruction. Surgery 81:610–612PubMed Sachatello CR (1977) The axillopectoral muscle (Langer’s axillary arch): a cause of axillary vein obstruction. Surgery 81:610–612PubMed
17.
Zurück zum Zitat Haagensen CD (1986) Diseases of the breast, 3rd edn. W.B. Saunders Co, Philadelphia, pp 882–883 Haagensen CD (1986) Diseases of the breast, 3rd edn. W.B. Saunders Co, Philadelphia, pp 882–883
18.
Zurück zum Zitat Tountas CP, Bergman RA (1993) Anatomic variations of the upper extremity. Churchill Livingstone, New York, pp 79–81 Tountas CP, Bergman RA (1993) Anatomic variations of the upper extremity. Churchill Livingstone, New York, pp 79–81
19.
Zurück zum Zitat Clarys JP, Barbaix E, Van Rompaey H, Caboor D, Van Roy P (1996) The muscular arch of the axilla revisited: its possible role in the thoracic outlet and shoulder instability syndromes. Man Ther 1:133–139. doi:10.1054/math.1996.0261 CrossRefPubMed Clarys JP, Barbaix E, Van Rompaey H, Caboor D, Van Roy P (1996) The muscular arch of the axilla revisited: its possible role in the thoracic outlet and shoulder instability syndromes. Man Ther 1:133–139. doi:10.​1054/​math.​1996.​0261 CrossRefPubMed
25.
Zurück zum Zitat Clark E (1915) Congenital variation of the pectoral muscles, with report of a case. J Anat Physiol 49:155–164PubMed Clark E (1915) Congenital variation of the pectoral muscles, with report of a case. J Anat Physiol 49:155–164PubMed
26.
27.
Zurück zum Zitat Lin C (1988) Contracture of the chondroepitrochlearis and the axillary arch muscles. A case report. J Bone Joint Surg Am 70:1404–1406PubMed Lin C (1988) Contracture of the chondroepitrochlearis and the axillary arch muscles. A case report. J Bone Joint Surg Am 70:1404–1406PubMed
Metadaten
Titel
Abnormal muscles that may affect axillary lymphadenectomy: surgical anatomy
verfasst von
K. Natsis
K. Vlasis
T. Totlis
G. Paraskevas
G. Noussios
P. Skandalakis
J. Koebke
Publikationsdatum
01.02.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0374-5

Weitere Artikel der Ausgabe 1/2010

Breast Cancer Research and Treatment 1/2010 Zur Ausgabe

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.